Texas Instruments Total Cost of Revenue increased by 3.8% to $2.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.4%, from $1.76B to $2.03B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 6.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.50B | $1.49B | $1.48B | $1.46B | $1.59B | $1.62B | $1.58B | $1.52B | $1.62B | $1.72B | $1.65B | $1.57B | $1.61B | $1.68B | $1.69B | $1.76B | $1.87B | $2.02B | $1.95B | $2.03B |
| QoQ Change | — | -0.8% | -0.6% | -1.3% | +8.5% | +2.3% | -2.5% | -4.2% | +6.9% | +5.9% | -4.1% | -4.9% | +2.9% | +4.1% | +1.0% | +3.7% | +6.7% | +7.8% | -3.4% | +3.8% |
| YoY Change | — | — | — | — | +5.6% | +8.9% | +6.8% | +3.6% | +2.1% | +5.7% | +4.0% | +3.3% | -0.6% | -2.3% | +2.9% | +12.1% | +16.3% | +20.4% | +15.2% | +15.4% |
| Segment | Q1 '25 | Q1 '26 |
|---|---|---|
| Analog | $1.30B | $1.59B |
| Embedded Processing | $375.00M | $374.00M |
| Other | $85.00M | $63.00M |
| Total | $1.76B | $2.03B |